| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Tarsus Pharmaceuticals, Inc. (TARS) has 8 insiders with recent SEC Form 4 filings, including 2 buys and 10 sells. TARS is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 858.0K | $56.32M | - | |
| Dir | 108.7K | $7.14M | - | |
| COO | 79.2K | $5.20M | - | |
| Other | 56.8K | $3.73M | - | |
| Other | 24.3K | $1.59M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 20, 2023 | Trevejo Jose M. | Chief Medical Officer | Sell | 2,252 | $20.00 | $45,040.00 | -50.0% | +57.5% | +159.9% | |
| Dec 15, 2023 | Goldberg Andrew D. | Director | Buy | 1,000 | $18.96 | $18,960.00 | +50.0% | +54.5% | +175.6% | |
| Nov 30, 2023 | Whitfield Dianne C. | Chief Human Resources Officer | Sale+OE | 8,355 | $16.31 | $136,270.05 | -23.8% | +129.1% | +217.3% | |
| Nov 30, 2023 | Wahl Bryan | General Counsel | Sale+OE | 8,356 | $16.31 | $136,286.36 | -20.7% | +129.1% | +217.3% | |
| Nov 15, 2023 | Azamian Bobak R.45 | President/ CEO And Board Chair | Sell | 8,000 | $18.37 | $146,933.12 | -0.3% | +65.4% | +160.2% | |
| Oct 18, 2023 | Azamian Bobak R.45 | President/ CEO And Board Chair | Sell | 8,000 | $13.24 | $105,920.00 | -0.9% | +70.0% | +178.7% | |
| Oct 5, 2023 | Trevejo Jose M. | Chief Medical Officer | Sell | 1,604 | $18.00 | $28,872.00 | -26.3% | +7.9% | +83.0% | |
| Sep 20, 2023 | Azamian Bobak R.45 | President/ CEO And Board Chair | Sell | 8,000 | $17.21 | $137,680.00 | -0.9% | +14.3% | +106.6% | |
| Aug 23, 2023 | Azamian Bobak R.45 | President/ CEO And Board Chair | Sell | 8,000 | $17.23 | $137,840.00 | -0.9% | +1.3% | +45.9% | |
| Aug 15, 2023 | Lin Elizabeth Yeu | Director | Buy | 9,506 | $16.80 | $159,700.80 | +149.5% | +1.0% | +56.8% |